CTU Bern (Clinical Trials Unit)

BERN TMVI

Mitral regurgitation is a frequent condition leading to relevant mortality and morbidity in elderly patients.

Surgical valve repair or replacement remains the treatment of choice in many patients. However, a relevant proportion of patients are treated conservatively because of high or inacceptable operative risk, primarily due to advanced age, reduced LV function and associated co-morbidities. Percutaneous mitral valve repair techniques have emerged as novel minimal-invasive treatment alternatives. BERN TMVI is a registry of patients undergoing Transcatheter Mitral Valve Interventions at the University Hospital Bern. The aim of registry is to assess Procedural safety of percutaneous mitral valve repair or replacement and Long-term clinical outcomes of patients undergoing the above-mentioned interventions up to 5 years follow up.